Indraprastha Medical rises 3% after HDFC Securities sees strong growth potential

Indraprastha Medical

18/04/2023 11:25

** Shares of Indraprastha Medical Corp  IMCL.NS  rise as
much as 3.43% to 87.4 rupees, the highest since Feb. 1
    ** Stock closed 1.42% higher
    ** Domestic brokerage HDFC Securities recommends to "buy"
IMCL between 82 rupees to 84 rupees, with base case PT of 93
rupees
    ** The healthcare company is a JV between Apollo Hospitals
Enterprise  APLH.NS  and state government of Delhi
    ** IMCL has immense growth potential; revenue well
diversified across specialities, including oncology, neurology,
cardiology - HDFC Securities
    ** Over 144,000 shares change hands as of 3:15 p.m. IST,
3.4x the 30-day avg. - Refinitiv
    ** Stock up 1.7% YTD as of last close; gained over 9% in
2022
    

 (Reporting by Nishit Navin in Bengaluru)
 ((Nishit.Navin@thomsonreuters.com ;))